Oppenheimer Downgrades ARIAD Pharmaceuticals (ARIA) to Perform
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.14 --0%
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 6
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 6
Join SI Premium – FREE
Oppenheimer downgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from Outperform to Perform with a price target of $23.00 (from $20.00).
For an analyst ratings summary and ratings history on ARIAD Pharmaceuticals click here. For more ratings news on ARIAD Pharmaceuticals click here.
Shares of ARIAD Pharmaceuticals closed at $22.79 yesterday.
For an analyst ratings summary and ratings history on ARIAD Pharmaceuticals click here. For more ratings news on ARIAD Pharmaceuticals click here.
Shares of ARIAD Pharmaceuticals closed at $22.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades DiaSorin SpA (DIA:IM) (DSRLF) to Sell
- MRF Ltd (MRF:IN) PT Raised to INR146,000 at Axis Capital Limited
- Landis+Gyr Group AG (LAND:SW) (LDGYY) PT Raised to CHF52 at UBS
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
